Patents by Inventor Norihito Nakata
Norihito Nakata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230094773Abstract: The RI-labeled anti-MUC5AC humanized antibody of the present invention is a conjugate of a chelating agent chelated with a radionuclide and an antibody (the radionuclide is a metal nuclide that emits ? particle or positron, and the antibody is a humanized antibody specifically binding to MUC5AC), and is superior in specificity for MUC5AC and accumulation in tumor. Therefore, it is extremely useful for the treatment and/or diagnosis of diseases in which MUC5AC is overexpressed, particularly cancer.Type: ApplicationFiled: May 26, 2022Publication date: March 30, 2023Applicants: NIHON MEDI-PHYSICS CO., LTD., SUMITOMO PHARMA CO., LTD.Inventors: Norihito Nakata, Nobuya Kobashi, Yoshinari Shoyama, Mitsuhiro Matono, Yasushi Ochiai, Takayuki Murakami
-
Patent number: 11369701Abstract: The RI-labeled anti-MUC5AC humanized antibody of the present invention is a conjugate of a chelating agent chelated with a radionuclide and an antibody (the radionuclide is a metal nuclide that emits ? particle or positron, and the antibody is a humanized antibody specifically binding to MUC5AC), and is superior in specificity for MUC5AC and accumulation in tumor. Therefore, it is extremely useful for the treatment and/or diagnosis of diseases in which MUC5AC is overexpressed, particularly cancer.Type: GrantFiled: July 2, 2021Date of Patent: June 28, 2022Assignees: NIHON MEDI-PHYSICS CO., LTD., SUMITOMO PHARMA CO., LTD.Inventors: Norihito Nakata, Nobuya Kobashi, Yoshinari Shoyama, Mitsuhiro Matono, Yasushi Ochiai, Takayuki Murakami
-
Publication number: 20210338852Abstract: The RI-labeled anti-MUC5AC humanized antibody of the present invention is a conjugate of a chelating agent chelated with a radionuclide and an antibody (the radionuclide is a metal nuclide that emits ? particle or positron, and the antibody is a humanized antibody specifically binding to MUC5AC), and is superior in specificity for MUC5AC and accumulation in tumor. Therefore, it is extremely useful for the treatment and/or diagnosis of diseases in which MUC5AC is overexpressed, particularly cancer.Type: ApplicationFiled: July 2, 2021Publication date: November 4, 2021Applicants: NIHON MEDI-PHYSICS CO., LTD., SUMITOMO DAINIPPON PHARMA CO., LTD.Inventors: Norihito Nakata, Nobuya Kobashi, Yoshinari Shoyama, Mitsuhiro Matono, Yasushi Ochiai, Takayuki Murakami
-
Publication number: 20210322582Abstract: The present invention provides a radiolabeled compound represented by the following formula (1), which is a radioactive imidazothiadiazole derivative compound having an affinity for CA-IX, or a salt thereof. wherein n is an integer of 1 to 4, and L represents a radionuclide or a mono- to tetravalent group containing a radionuclide.Type: ApplicationFiled: August 30, 2019Publication date: October 21, 2021Applicants: Nihon Medi-Physics Co., Ltd., Kyoto UniversityInventors: Masato KIRIU, Norihito NAKATA, Tsutomu ABE, Masahiro ONO
-
Publication number: 20200181196Abstract: The present invention relates to an IgG-binding peptide comprising a ligand capable of binding to a radioactive metal nuclide, an IgG-binding peptide labeled with a radioactive metal nuclide, a conjugate of the IgG-binding peptide and IgG, and a radionuclide imaging agent or a diagnostic agent for cancer comprising the IgG-binding peptide or the conjugate, etc.Type: ApplicationFiled: June 12, 2017Publication date: June 11, 2020Applicant: Kagoshima UniversityInventors: Yuji ITO, Yoshinari SHOYAMA, Akio HAYASHI, Norihito NAKATA
-
Patent number: 10037042Abstract: A valve control system for a steam turbine that decrease in effective power as well as secure control stability in the event of an electric power system accident is provided. A valve control system for a steam turbine includes an accident detection unit 44 which detects an occurrence of an electric power system accident, a first selection unit 45 which selects, from a plurality of control valves 13 (13a˜13d) which adjust a volume of steam flowing into a steam turbine, control valves 13 to be rapidly closed according to a scale of the accident detected, and a normal control circuit 11 which continues normal pressure or speed control by the control valves 13 which are not selected.Type: GrantFiled: February 18, 2014Date of Patent: July 31, 2018Assignee: KABUSHIKI KAISHA TOSHIBAInventors: Norihito Nakata, Toshio Aoki, Masaaki Matsumoto
-
Publication number: 20180193493Abstract: Provided is a method for imaging a renal lesion comprising the steps of administrating a nitroimidazole-based compound to a living body and obtaining an image of the renal lesion by detecting radiation non-invasively from the outside of the living body wherein the renal imaging agent comprises a defined nitroimidazole-based compound or a salt thereof. The step of obtaining the image of the renal lesion can include using positron emission tomography.Type: ApplicationFiled: March 8, 2018Publication date: July 12, 2018Applicant: NIHON MEDI-PHYSICS CO., LTD.Inventor: Norihito NAKATA
-
Publication number: 20170281803Abstract: The present invention provides a renal imaging agent comprising a nitroimidazole-type compound or a salt thereof. The renal imaging agent according to the present invention can be used in positron emission tomography.Type: ApplicationFiled: September 7, 2015Publication date: October 5, 2017Applicant: NIHON MEDI-PHYSICS CO., LTD.Inventor: Norihito NAKATA
-
Publication number: 20150378369Abstract: A valve control system for a steam turbine that decrease in effective power as well as secure control stability in the event of an electric power system accident is provided. A valve control system for a steam turbine includes an accident detection unit 44 which detects an occurrence of an electric power system accident, a first selection unit 45 which selects, from a plurality of control valves 13 (13a˜13d) which adjust a volume of steam flowing into a steam turbine, control valves 13 to be rapidly closed according to a scale of the accident detected, and a normal control circuit 11 which continues normal pressure or speed control by the control valves 13 which are not selected.Type: ApplicationFiled: February 18, 2014Publication date: December 31, 2015Applicant: KABUSHIKI KAISHA TOSHIBAInventors: Norihito NAKATA, Toshio AOKI, Masaaki MATSUMOTO
-
Patent number: 9107964Abstract: The present invention is a compound represented by the following formula (1) or a salt thereof. In the formula (1), R1 denotes a hydrogen atom, a methyl group, or a hydroxymethyl group, and n is an integer of 1 or 2.Type: GrantFiled: September 18, 2012Date of Patent: August 18, 2015Assignees: NIHON MEDI-PHYSICS CO., LTD., NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventors: Norihito Nakata, Yuki Okumura, Masato Kiriu, Eriko Nagata, Hiroki Matsumoto, Yuji Kuge, Songji Zhao, Ken-Ichi Nishijima
-
Publication number: 20140364620Abstract: The present invention is a compound represented by the following formula (1) or a salt thereof. In the formula (1), R1 denotes a hydrogen atom, a methyl group, or a hydroxymethyl group, and n is an integer of 1 or 2.Type: ApplicationFiled: September 18, 2012Publication date: December 11, 2014Applicant: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITYInventors: Norihito Nakata, Yuki Okumura, Masato Kiriu, Eriko Nagata, Hiroki Matsumoto, Yuji Kuge, Songji Zhao, Ken-Ichi Nishijima